Articles

Of the five Republicans who took the stage Wednesday night for the latest GOP presidential debate, only two showed that they were serious about fixing Social Security and Medicare. 

The FDA warns people should stop using more than two dozen eye-drop products that pose a risk of infection, which could cause partial vision loss or blindness.

With Eli Lilly’s Zepbound set to enter the fray, companies are flooded with weight-loss drug questions

The more than two dozen tainted eye drops that the FDA warned could cause infection and vision loss have been traced back to an unsanitary factory, according to a report.

U.S. consumer sentiment fell in November for the fourth month in a row due to worries about higher interest rates as well as ongoing war in the Middle East.

China chip foundry giant Semiconductor Manufacturing International Corp. reported plunging profits and sales on Friday.

A bullish stock market indicator with a sterling track record arrived last week. And technical analysts on Wall Street haven't stopped talking about it.

Drugmaker set to expand Danish facilities amid ongoing Wegovy shortage.

British billionaire Sir Jim Ratcliffe is reportedly close to clinching a deal to become a minority stakeholder in Manchester United. 

As SoFi shares slid this week, two executives bought up stock.

Shares in Richemont led Europe's luxury goods sector lower on Friday, after the Swiss-based group said geopolitical angst and a weakening European economy had delivered lower than expected first-half profits.

Post Content